NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/03/2026
Back to search
Official data from USPTO
AXXELENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/04/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
03/15/2019
Registration date
03/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2026
Last transaction
03/04/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
5
Owner type
01
Owner location
Chennai, IN
Examiner
ELTON, DAVID JONATHAN
Current location
Historical data usage
Holders and representatives
Holders
J. D. (pessoa física)
J. D. (pessoa física)
Representatives
Louis J. Levy Symbus Law Group PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal and pharmaceutical preparations for use in the syndromic approach for treating painheadachefevercoughsshockdehydrationhypoglycemiaoral and dental conditionsgastrointensal conditionsrespiratory diseaseobstetrical/gynecological conditionscardiovascular diseaseskin diseasesallergic reactionsmusculo-skeletal and joint diseaseskidney and urological disordersotolaryngological diseaseseye diseasesneurological system diseasesmetabolic and endocrinological diseaseshematological diseasesmalignant diseasesprotozoal infections and conditionssexually transmitted infectionsHIV and other viral infectionsnutritional disorders and poisoning; pharmaceutical preparationscontraceptive preparations
Class 42
Scientific and medical research and development in the fields of medicinesdiagnostic aids and radio-pharmaceuticals for the treatment of painheadachesfeverscoughsshockdehydrationhypoglycemiaoral and dental conditionsgastrointestinal conditionsrespiratory conditionsobstetrical/gynecological conditions and contraceptioncardiovascular conditionsskin diseases and allergic reactionsmusculo-skeletal and joint conditionskidney and urological disordersotolaryngological disearcehseye conditionsneurological conditionsmetabolic and endorcinological conditionshematolical conditionstrauma and injuriesmalignant disease conditionsmalariatuberculosisleprosysexually transmitted infectionsHIV and other viral infections and conditionsprotozoa infections and conditionspoisoning; medical research laboratory services; providing medical and veterinary research information in relation to all of the above; providing medical and scientific research information in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
39 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
03/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
ES71
TEAS SECTION 71 RECEIVED
10/16/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/08/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/14/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/29/2020
FIMP
FINAL DISPOSITION PROCESSED
07/28/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2019
PUBO
PUBLISHED FOR OPPOSITION
12/31/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/21/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/21/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/21/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2019
ALIE
ASSIGNED TO LIE
10/28/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/23/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2019
RFNT
REFUSAL PROCESSED BY IB
09/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/19/2019
RFRR
REFUSAL PROCESSED BY MPU
08/19/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/28/2019
CNRT
NON-FINAL ACTION WRITTEN
07/27/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2019
DOCK
ASSIGNED TO EXAMINER
07/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/18/2019
Continuous trademark protection
Get notified about every new filing that threatens AXXELENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.